The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis

European Journal of Cell Biology

Volumn 92, Issue 4-5, 2013, Pages 150-159

  Yin, Yanlin ^a   Liu, Weiwei ^a   Ji, Guo ^a   Dai, Yalei ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Atherosclerosis; IL 10; LOX 1; MAPK; OxLDL; SOCS3; Vascular endothelial cells

Indexed keywords

INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SUPPRESSOR OF CYTOKINE SIGNALING 3;

APOPTOSIS; ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

APOPTOSIS; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-10; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPROTEINS, LDL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SCAVENGER RECEPTORS, CLASS E; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84877630883     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2013.01.001     Document Type: Article

References (56)

1. Berlato C., Cassatella M.A., Kinjyo I., Gatto L., Yoshimura A., Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 2002, 168:6404-6411.
2. Boronkai A., Bellyei S., Szigeti A., Pozsgai E., Bognar Z., Sumegi B., Gallyas F. Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells. Eur. J. Cell Biol. 2009, 88:753-763.
3. Caligiuri G., Rudling M., Ollivier V., Jacob M.P., Michel J.B., Hansson G.K., Nicoletti A. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 2003, 9:10-17.
4. Cassatella M.A., Gasperini S., Bovolenta C., Calzetti F., Vollebregt M., Scapini P., Marchi M., Suzuki R., Suzuki A., Yoshimura A. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood 1999, 94:2880-2889.
5. Chen J., Mehta J.L., Haider N., Zhang X., Narula J., Li D. Role of caspases in oxLDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ. Res. 2004, 94:269-270.
6. Choi J.S., Choi Y.J., Shin S.Y., Li J., Kang S.W., Bae J.Y., Kim D.S., Ji G.E., Kang J.S., Kang Y.H. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-Signaling. J. Nutr. 2008, 138:983-990.
7. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109:III27-III32.
8. Dhingra S., Sharma A.K., Singla D.K., Singal P.K. p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3524-H3531.
9. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:812-819.
10. Fu R., Yan T., Wang Q., Guo Q., Yao H., Wu X., Li Y. Suppression of endothelial cell adhesion by XJP-1, a new phenolic compound derived from banana peel. Vascul. Pharmacol. 2012, 57:105-112.
11. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 2009, 27:165-197.
12. George J., Schwartzenberg S., Medvedovsky D., Jonas M., Charach g., Afek A., Shamiss A. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis 2012, 222:519-523.
13. Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schäffer A.A., Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D., Hätscher N., Pfeifer D., Sykora K.W., Sauer M., Kreipe H., Lacher M., Nustede R., Woellner C., Baumann U., Salzer U., Koletzko S., Shah N., Segal A.W., Sauerbrey A., Buderus S., Snapper S.B., Grimbacher B., Klein C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 2009, 361:2033-2045.
14. Halvorsen B., Waehre T., Scholz H., Clausen O.P., von der Thüsen J.H., Müller F., Heimli H., Tonstad S., Hall C., Frøland S.S., Biessen E.A., Damås J.K., Aukrust P. Interleukin-10 enhances the oxidized LDL induced foam cell formation of macrophages by antiapoptotic mechanisms. J. Lipid Res. 2005, 46:211-219.
15. Jeong Y.J., Choi Y.J., Kwon H.M., Kang S.W., Park H.S., Lee M., Kang Y.H. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids. Br. J. Nutr. 2005, 93:581-591.
16. Jones S.P., Trocha S.D., Lefer D.J. Cardioprotective actions of endogenous IL-10 are independent of iNOS. Am. J. Physiol. Heart Circ. Physiol. 2001, 281:48-52. 2001.
17. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008, 79:360-376.
18. Komyod W., Böhm M., Metze D., Heinrich P.C., Behrmann I. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line. Mol. Cancer Res. 2007, 5:271-281.
19. Kontoyiannis D., Kotlyarov A., Carballo E., Alexopoulou L., Blackshear P.J., Gaestel M., Davis R., Flavell R., Kollias G. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 2001, 20:3760-3770.
20. Leghmari K., Bennasser Y., Bahraoui E. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways. Eur. J. Cell Biol. 2008, 87:947-962.
21. Lentsch A.B., Shanley T.P., Sarma V., Ward P.A. In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J. Clin. Invest. 1997, 100:2443-2448.
22. Li D., Mehta J.L. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1116-1122.
23. Li D., Williams V., Liu L., Chen H., Sawamura T., Romeo F., Mehta J.L. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J. Am. Coll. Cardiol. 2003, 41:1048-1055.
24. Li D.Y., Chen H.J., Staples E.D., Ozaki K., Annex B., Singh B.K., Vermani R., Mehta J.L. Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J. Cardiovasc. Pharmacol. Ther. 2002, 7:147-153.
25. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
26. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
27. Madonna S., Scarponi C., Pallotta S., Cavani A., Albanesi C. Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis. Cell Death Dis. 2012, 3:e334.
28. Mallat Z., Tedgui A. Apoptosis in the vasculature: mechanisms and functional importance. Br. J. Pharmacol. 2000, 130:947-962.
29. Mehta J.L., Li D.Y. Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem. Biophys. Res. Commun. 1998, 248:511-514.
30. Mietus-Snyder M., Gowri M.S., Pitas R.E. Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J. Biol. Chem. 2000, 275:17661-17670.
31. Mitra S., Goyal T., Mehta J.L. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc. Drug Ther. 2011, 25:419-429.
32. Nihei S., Yamashita K., Tasaki H., Ozumi K., Nakashima Y. Oxidized low-density lipoprotein-induced apoptosis is attenuated by insulin-activated phosphatidylinositol 3-kinase/Akt through p38 mitogen-activated protein kinase. Clin. Exp. Pharmacol. Physiol. 2005, 32:224-229.
33. Niiro H., Otsuka T., Ogami E., Yamaoka K., Nagano S., Akahoshi M., Nakashima H., Arinobu Y., Izuhara K., Niho Y. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem. Biophys. Res. Commun. 1998, 250:200-205.
34. Nowicki M., Zabirnyk O., Duerrschmidt N., Borlak J., Spanel-Borowski K. No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy. Eur. J. Cell Biol. 2007, 86:605-616.
35. Ogura S., Kakino A., Sato Y., Fujita Y., Iwamoto S., Otsui K., Yoshimoto R., Sawamura T. LOX-1 - the multifunctional receptor underlying cardiovascular dysfunction. Circ. J. 2009, 73:1993-1999.
36. Paul G., Khare V., Gasche C. Inflamed gut mucosa: downstream of interleukin-10. Eur. J. Clin. Invest. 2012, 42:95-109.
37. Puhr M., Santer F.R., Neuwirt H., Marcias G., Hobisch A., Culig Z. SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling. Endocr. Relat. Cancer 2010, 17:525-538.
38. Rahaman S.O., Lennon D.J., Febbraio M., Podrez E.A., Hazen S.L., Silverstein R.L. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab. 2006, 4:211-221.
39. Rubic T., Lorenz R.L. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc. Res. 2006, 69:527-535.
40. Schottelius A.J., Mayo M.W., Sartor R.B., Baldwin A.S. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J. Biol. Chem. 1999, 274:31868-31874.
41. Su X., Ao L., Shi Y., Johnson T.R., Fullerton D.A., Meng X. Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via toll-like receptors 2 and 4. J. Biol. Chem. 2011, 286:12213-12220.
42. 2-terminal kinase regulates manganese superoxide dismutase ubiquitination: Implication for mitochondrial redox status and apoptosis. Arterioscler. Thromb. Vasc. Biol. 2010, 30:436-441.
43. Takahashi M., Okazaki H., Ogata Y., Takeuchi K., Ikeda U., Shimada K. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis 2002, 161:387-394.
44. Tedgui A., Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ. Res. 2001, 88:877-887.
45. Terkeltaub R.A. IL-10: An " immunologic scalpel" for atherosclerosis?. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2823-2825.
46. -/- mice. FASEB J. 2001, 15:2730-2742.
47. Wang F., Dai Y., Xu T., Xu B., Wang K. Effect of IL-10 on formation of foam cell induced by ox-LDL. Front. Med. China 2008, 2:298-302.
48. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 1994, 153:811-816.
49. Wang Y.Q., Dai M., Zhong J.C., Yin D.K. Paeonol inhibits oxidized low density lipoprotein-induced monocyte adhesion to vascular endothelial cells by inhibiting the mitogen activated protein kinase pathway. Biol. Pharm. Bull. 2012, 35:767-772.
50. Ward C., Murray J., Clugston A., Dransfield I., Haslett C., Rossi A.G. Interleukin-10 inhibits lipopolysaccharide-induced survival and extracellular signal-regulated kinase activation in human neutrophils. Eur. J. Immunol. 2005, 35:2728-2737.
51. Wu C.Y., Tang Z.H., Jiang L., Li X.F., Jiang Z.S., Liu L.S. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway. Mol. Cell. Biochem. 2012, 359:347-358.
52. Yang H., Chen S., Tang Y., Dai Y. Interleukin-10 down-regulates oxLDL induced expression of scavenger receptor A and Bak-1 in macrophages derived from THP-1 cells. Arch. Biochem. Biophys. 2011, 512:30-37.
53. Yang H., Chen S.C., Tang Y.Q., Dai Y.L. Effect of overexpression of human SR-AI on oxLDL uptake and apoptosis in 293T cells. Int. Immunopharmacol. 2011, 11:1752-1757.
54. Yang H., Chen S.C. The effect of interleukin-10 on apoptosis in macrophages stimulated by oxLDL. Eur. J. Pharmacol. 2011, 657:126-130.
55. Yoshimoto R., Fujita Y., Kakino A., Iwamoto S., Takaya T., Sawamura T. The discovery of LOX-1, its ligands and clinical significance. Cardiovasc. Drugs Ther. 2011, 225:379-391.
56. Zhao M., Liu Y., Wang X., New L., Han J., Brunk U.T. Activation of the p38 MAP kinase pathway is required for foam cell formation from macrophages exposed to oxidized LDL. APMIS 2002, 110:458-468.